Eli A. Friedman, M.D.

Within the past three years, Dr. Friedman has received grant/research support from Alteon.

Release Date: 06/03/2002
Termination Date: 06/03/2002

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

• Classify and chart the course of proteinuria in the nephropathy complicating type 1 and type 2 diabetes
• Discuss the timing and value of interventions that retard the progression of diabetic nephropathy, highlighting the value of drugs that impede the rennin-angiotensin system
• Stage the course of diabetic nephropathy planning timing of therapy for chronic renal failure.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity